A 4D-QSAR study on anti-HIV HEPT analogues.

We used the 4D-QSAR method coupled with the PLS analysis and uninformative variable elimination or its variants for the investigations of the antiviral activity of HEPT, a series of conformationally flexible molecules that bind HIV-1 reverse transcriptase. An analysis of several Hopfinger's and SOM-4D-QSAR models indicated that both methods yield comparable results. Generally, charge descriptors provide better modeling efficiency. We have shown that the method properly indicates the mode of interaction revealed by X-ray studies. It also allows us to calculate highly predictive QSAR models.

[1]  C. Monneret,et al.  Synthesis and anti-HIV activity of novel N-1 side chain-modified analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). , 1997, Journal of medicinal chemistry.

[2]  L. A. Stone,et al.  Computer Aided Design of Experiments , 1969 .

[3]  C. Monneret,et al.  A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition. , 1997, Journal of medicinal chemistry.

[4]  Anton J. Hopfinger,et al.  Prediction of Ligand-Receptor Binding Free Energy by 4D-QSAR Analysis: Application to a Set of Glucose Analogue Inhibitors of Glycogen Phosphorylase , 1999, J. Chem. Inf. Comput. Sci..

[5]  Steven D. Young,et al.  Non-nucleoside inhibitors of HIV-1 reverse transcriptase , 1993 .

[6]  I. Helland.  Some theoretical aspects of partial least squares regression , 2001 .

[7]  Erik De Clercq,et al.  HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase , 1993, Medicinal research reviews.

[8]  Anton J. Hopfinger,et al.  3D-Pharmacophores of Flavonoid Binding at the Benzodiazepine GABAA Receptor Site Using 4D-QSAR Analysis , 2003, J. Chem. Inf. Comput. Sci..

[9]  W. Schäfer,et al.  Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and X-ray structure investigations. , 1993, Journal of medicinal chemistry.

[10]  T. Iwata,et al.  Elimination of the Uninformative Calibration Sample Subset in the Modified UVE(Uninformative Variable Elimination)–PLS (Partial Least Squares) Method , 2001, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[11]  S. Gayen,et al.  QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters. , 2004, Bioorganic & medicinal chemistry.

[12]  Juan M. Luco,et al.  QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT Derivatives , 1997, J. Chem. Inf. Comput. Sci..

[13]  Jaroslaw Polanski,et al.  Modeling Steric and Electronic Effects in 3D- and 4D-QSAR Schemes: Predicting Benzoic pKa Values and Steroid CBG Binding Affinities , 2003, J. Chem. Inf. Comput. Sci..

[14]  Richard T. Walker,et al.  Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. , 1996, Journal of medicinal chemistry.

[15]  Supa Hannongbua,et al.  3D-Quantitative Structure-Activity Relationships of HEPT Derivatives as HIV-1 Reverse Transcriptase Inhibitors, Based on Ab Initio Calculations , 2001, J. Chem. Inf. Comput. Sci..

[16]  A. Hopfinger,et al.  Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism , 1997 .

[17]  Jaroslaw Polanski,et al.  Self-organizing neural networks for modeling robust 3D and 4D QSAR: application to dihydrofolate reductase inhibitors. , 2004, Molecules.

[18]  Mehdi Jalali-Heravi,et al.  Use of Artificial Neural Networks in a QSAR Study of Anti-HIV Activity for a Large Group of HEPT Derivatives , 2000, J. Chem. Inf. Comput. Sci..

[19]  L Douali,et al.  Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives. , 2003, Current pharmaceutical design.

[20]  Desire L. Massart,et al.  Detection of inhomogeneities in sets of NIR spectra , 1996 .

[21]  Mahindra T. Makhija,et al.  De novo design and synthesis of HIV-1 integrase inhibitors. , 2004, Bioorganic & medicinal chemistry.

[22]  A J Hopfinger,et al.  4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. , 2002, Journal of medicinal chemistry.

[23]  Jaroslaw Polanski,et al.  The Comparative Molecular Surface Analysis (CoMSA) with Modified Uniformative Variable Elimination-PLS (UVE-PLS) Method: Application to the Steroids Binding the Aromatase Enzyme , 2003, J. Chem. Inf. Comput. Sci..

[24]  S. Wold,et al.  The kernel algorithm for PLS , 1993 .

[25]  Jaroslaw Polanski,et al.  GRID Formalism for the Comparative Molecular Surface Analysis: Application to the CoMFA Benchmark Steroids, Azo Dyes, and HEPT Derivatives , 2004, J. Chem. Inf. Model..

[26]  Fabrizio Manetti,et al.  HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. , 2005, Journal of medicinal chemistry.

[27]  R T Walker,et al.  A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. , 1989, Journal of medicinal chemistry.

[28]  S. Wold,et al.  PLS-regression: a basic tool of chemometrics , 2001 .